Nabih Maslah

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Cardiovascular Risk Factors

Acute Lymphoblastic Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia (2024)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Nabih Maslah, Emmanuelle Verger, Stéphane Giraudier, Mathias Chea, Ronald Hoffman, John O Mascarenhas, Bruno Cassinat, Jean-Jacques Kiladjian
Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition. Blood advances 6 (9) (2022)
Clémence Marcault, Lin-Pierre Zhao, Nabih Maslah, Emmanuelle Verger, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Marine Cazaux, Nicolas Gauthier, Blandine Roux, Emmanuelle Clappier, Nathalie Parquet, Christine Dosquet, Delphine Rea, Jean-Marc Zini, William Vainchenker, Emmanuel Raffoux, Stéphane Giraudier, Jean-Jacques Kiladjian, Bruno Cassinat, Lina Benajiba
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood 138 (21) (2021)